UK Supreme Court affirms Warner-Lambert’s pregabalin patent is invalid
Warner-Lambert patent was insufficiently disclosed and would not have been infringed by generics even if the claims were valid, in a ruling that raises the bar for plausibility of Swiss form claims
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
